Journal of Clinical Oncology | 2024
Post-Transplant Cyclophosphamide based Graft-versus-Host Disease Prophylaxis Eliminates Disparities in Outcomes Between Matched and Mismatched Unrelated Donor Hematopoietic Cell Transplantation.
Shaffer BC, Gooptu M, DeFor TE, Maiers M, Bolaños-Meade J, Abboud R, Briggs AD, Khimani F, Modi D, Newcomb R, Shpall EJ, Bupp C, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez Jimenez AM, Al Malki MM
PubMed
PMID: 39018507
Abstract
Related Articles
CIBMTR Study #: CIBMTR_NA
Dataset Files:
This dataset was collected by the Center for International Blood and Marrow Transplant Research (CIBMTR) which is supported primarily by the Public Health Service U24CA076518 from the National Cancer Institute; the National Heart, Lung, and Blood Institute; the National Institute of Allergy and Infectious Diseases; 75R60222C00011 from the Health Resources and Services Administration; N00014-23-1-2057 and N00014-24-1-2057 from the Office of Naval Research; NMDP; and the Medical College of Wisconsin. By downloading the dataset files below, you agree to the Terms and Conditions.
I agree to the Terms and Conditions; Download Dataset
I agree to the Terms and Conditions; Download Data Dictionary